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Abstract
Background: In 2004, tuberculosis (TB) was responsible for 2.5% of global mortality (among men
3.1%; among women 1.8%) and 2.2% of global burden of disease (men 2.7%; women 1.7%). The
present work portrays accumulated evidence on the association between alcohol consumption and
TB with the aim to clarify the nature of the relationship.
Methods: A systematic review of existing scientific data on the association between alcohol
consumption and TB, and on studies relevant for clarification of causality was undertaken.
Results: There is a strong association between heavy alcohol use/alcohol use disorders (AUD) and
TB. A meta-analysis on the risk of TB for these factors yielded a pooled relative risk of 2.94 (95%
CI: 1.89-4.59). Numerous studies show pathogenic impact of alcohol on the immune system causing
susceptibility to TB among heavy drinkers. In addition, there are potential social pathways linking
AUD and TB. Heavy alcohol use strongly influences both the incidence and the outcome of the
disease and was found to be linked to altered pharmacokinetics of medicines used in treatment of
TB, social marginalization and drift, higher rate of re-infection, higher rate of treatment defaults and
development of drug-resistant forms of TB. Based on the available data, about 10% of the TB cases
globally were estimated to be attributable to alcohol.
Conclusion: The epidemiological and other evidence presented indicates that heavy alcohol use/
AUD constitute a risk factor for incidence and re-infection of TB. Consequences for prevention
and clinical interventions are discussed.
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Background
Tuberculosis (TB) continues to be one of the major causes
of death and disability. The Global Burden of Disease
Study estimated that in 2004 TB was responsible for 2.5%
of global mortality (among men 3.1%; women 1.8%) and
2.2% of global burden of disease (men 2.7%; women
1.7%), with more impact in developing countries [1].
While the current disease burden is enormous, and TB
qualifies among the 10 most fatal and disabling disease
categories, the relative impact of TB has been going down
over time. For instance, at the time of its discovery by Rob-
ert Koch in 1882, Mycobacterium (M.) tuberculosis, the eti-
ologic agent of TB, was responsible for almost one-
seventh of all the deaths in Europe [2].
The association between alcohol use and TB has long been
known, even before the aetiology of TB became known.
Benjamin Rush as early as 1785 listed TB and pneumonia
as infectious sequelae of sustained heavy drinking [3].
Since then, there have been numerous publications
describing the associations between alcohol, alcohol use
disorders (AUD) and TB (e.g.,[4,5]). However, the precise
nature of the relationship has been in dispute. For
instance, Rieder [6] (1999, p. 77) stated that "... epidemi-
ologic evidence of a causal association [between alcohol
abuse and TB] is inconclusive. The postulated association
is confounded with environments (in industrialized
countries at least) which are conducive for increased
transmission and thus infection with M. tuberculosis." In
other words, confounding by other factors could not be
excluded.
We propose that, by now, enough evidence has accumu-
lated to postulate a causal impact of alcohol use on both
the incidence and the course of TB. In this paper, we will
try to summarize this evidence, using the standard criteria
for causality in epidemiology [7,8]: association and
strength of association, temporality, consistency, dose-
response relationship, plausibility of biological pathways,
exclusion of confounding and alternative explanations,
and reversibility following interventions. In our analysis
we will rely heavily on the review and meta-analysis of
Lönnroth and colleagues [9], but include new data on the
association in different populations as well as two new
meta-analyses on alcohol as a risk factor for TB clustering.
Method
Systematic literature review on epidemiological 
prevalence studies
AMSTAR, a measurement tool to assess the methodologi-
cal quality of systematic reviews [10], and the overview by
Egger and colleagues [11] were used as a guide to conduct
this systematic literature review.
A systematic literature search on individual epidemiolog-
ical studies reporting a prevalence of a) heavy alcohol use/
AUD among TB patients and b) TB among patients with
AUD was performed in multiple electronic bibliographic
databases including: Ovid MEDLINE, PubMed, EMBASE,
Web of Science (including Science Citation Index, Social
Sciences Citation Index, Arts and Humanities Citation
Index), PsycINFO, CABS (BIDS), WHOLIST, SIGLE,
ETOH, Google Scholar, and the Cochrane Database of
Systematic Reviews. The available published and unpub-
lished literature was searched up to September 2008
inclusive. The search was conducted using multiple com-
binations of the following key words: tuberculosis, alco-
hol, abuse, misuse, dependence, alcohol use disorders,
prevalence and incidence. In addition, a manual search of
the bibliographic pages of selected articles and reviews as
well as the content pages of major epidemiological jour-
nals [including The International Journal of Tuberculosis
and Lung Disease (IJTLD)] were conducted. The search
was not limited geographically and to English language
publications.
Studies were excluded from the analysis for any of the fol-
lowing reasons: article did not have sufficient data on
prevalence of heavy alcohol use/AUD among TB patients
or of TB among patients with AUD; a meta-analysis or sys-
tematic review; duplicate publication of the same study;
and articles available in abstract form only.
Data extraction
The titles and abstracts, where available, were independ-
ently reviewed by two researchers to identify potentially
relevant papers. The papers were obtained and independ-
ently read in full by two researchers. Differences were
resolved by discussion and a third party, if necessary. Rea-
sons for exclusion were identified. The data were extracted
based on the inclusion and exclusion criteria defined
above.
Training of coders to achieve sufficient (> 0.80) interrater
reliability was conducted. Interrater reliability gives a
score of how much homogeneity, or consensus, there is in
the ratings given by different raters. In order to calculate
interrater reliability, Fleiss' kappa statistics using the
attribute agreement analytic method was used [12].
Using a standardized Excel spreadsheet, each study was
coded for the following variables: reference, setting [coun-
try/study years], study sample, type of TB, percent of
patients with: a) heavy alcohol use/AUD among TB
patients and b) TB in patients with an AUD diagnosis, and
definition of heavy alcohol use/AUD. A second member
cross-checked the table entries for accuracy, against the
original article.BMC Public Health 2009, 9:450 http://www.biomedcentral.com/1471-2458/9/450
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The quality of the data from individual articles was
assessed based on the following domains as recom-
mended by U.S. Department of Health and Human Serv-
ices [13]: comparability of subjects, exposure, outcome
measurement, and funding or sponsorship.
The literature search for different causal criteria and 
pathways
In the literature search for different causal criteria and
pathways, priority was given to systematic reviews and
meta-analyses. Special search strategies [14] were used.
The same data bases as for the other research were used,
with the key words alcohol, TB, plus one of the following:
longitudinal, consistency, dose-response relationship,
biological pathways, confounding, and reversibility. Only
the most comprehensive reviews were included for the
discussion of different causal criteria.
Estimation of a) standardized mortality rates in Russia and 
the Ukraine and b) alcohol-attributable fractions (AAFs) 
for TB deaths
Comparison of the standardized mortality rates in Russia
and the Ukraine was based on the WHO mortality data
bank (European standard population).
AAFs for TB deaths in 2002 in selected countries were cal-
culated based on relative risk (RR) information from the
most recent meta-analysis [9]. AAFs were calculated using
the formulas of Walter [15,16], using a disaggregated
approach with 5 age groups (15-29; 30-44; 45-59; 60-69;
70+ years). For exposure, we used the estimates of heavy
drinking from the 2002 Comparative Risk Analyses for
WHO [17]. This model is restricted to adults and only cap-
tures the effect of alcohol on oneself, not potential effects
on others in spreading the disease.
Even though these studies [14] controlled for some con-
founding, residual confounding of social and other risk
factors for TB such as smoking or drug taking cannot be
ruled out [18]. Unfortunately, there is no sufficient basis
for the quantification of confounding. To be conservative,
we use the standard method for potential confounding of
tobacco risks (i.e. halving the effect) [19].
Ethics committee approval
The underlying work is based on systematic reviews of
published data, and thus did not require ethical review.
Results
Systematic literature review on epidemiological 
prevalence studies to establish association between heavy 
alcohol use/AUD and TB
The electronic searches yielded a total of 1,537 publica-
tions regarding epidemiological prevalence studies (Fig-
ure 1).
After 321 duplicate articles were removed, 1,216 were
screened using titles and abstracts. 432 full-text articles
were retrieved for further consideration. Cross-checking of
references and hand-searches of the IJTLD did not yield
any additional studies to be included. A total of 53 studies
met inclusion criteria: 47 studies reported a prevalence of
heavy alcohol use/AUD among TB patients and 6 studies
reported a prevalence of TB among patients with AUD.
Studies were in English (50), Russian (2) and Romanian
(1) languages. A list of excluded studies is available from
the authors. The studies were found for the following
countries: USA (29 studies), Russia (5), Canada (4), Den-
mark (3), India (3), Brazil (2); and one study in each of
Australia, Belarus, Finland, Germany, Kazakhstan, Roma-
nia, Slovenia, Sweden, and the UK.
The literature search for different causal criteria and 
pathways
At least one meta-analysis or systematic review was found
for each of the causal criteria, except for establishing the
dose-response relationship and reversibility. In the fol-
lowing, the results with respect to the causal criteria will
be presented and discussed under the respective subhead-
ing. A general discussion will follow.
Association and strength of association
There have been clear associations found between heavy
alcohol use/AUD, variously defined, and TB. Additional
file 1 provides an overview of the prevalence of heavy
alcohol use/AUD in various samples of TB patients. The
prevalence of heavy alcohol use/AUD in most samples of
men and women is markedly higher than in the general
population, or than in matched control groups. As
expected, the prevalence of TB among people with AUD
was also elevated (see additional file 2). In addition, TB
was found to be a major cause of death among people
with AUD [20].
A formal meta-analysis, conducted by one of the co-
authors of the present manuscript, was based on 3 cohort
and 18 case-control studies with individual-level data on
alcohol exposure and TB [11]. The objective was to sys-
tematically review alcohol use as a risk factor for active TB.
The pooled RR across the 11 studies that used an exposure
cut-off level set at 40 g alcohol per day or above, or
defined exposure as a clinical diagnosis of an AUD, was
3.50 (95% CI: 2.01-5.93). After exclusion of 3 small stud-
ies, because of suspected publication bias, the pooled RR
was 2.94 (95% CI: 1.89-4.59). Several sensitivity analyses
confirmed this substantial risk of TB for heavy alcohol use
or AUD [9]. The pooled effect size across studies that had
controlled for infection status (OR 4.21, 95% CI: 2.73-
6.48), suggest that one possible causal pathway is through
increased risk of progression from infection to disease.
This meta-analysis did not find an association betweenBMC Public Health 2009, 9:450 http://www.biomedcentral.com/1471-2458/9/450
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consumption of less than 40 g alcohol per day and risk of
TB.
Two recent meta-analyses have assessed risk factors for TB
clustering (as a marker for recent TB transmission), and
both found that alcohol abuse (not further defined) was a
risk factor for clustering. The first, which was based on 36
genotyping studies in 17 countries [21], found significant
effects of alcohol abuse on TB clustering for both low TB
incidence (OR = 2.6; 95% CI: 2.1-3.3) and high TB inci-
dence (OR = 1.4; 95% CI: 1.1-1.9) studies. The significant
effects remained after adjustment [21]. The other meta-
analysis, based on 30 studies, reported that recent trans-
mission of TB was associated with heavy alcohol use (OR
2.27; 95% CI: 1.69-3.06) [18].
In summary, the evidence indicates a clear and strong
association between heavy alcohol use/AUD and both risk
of developing active TB and risk of recent TB transmission.
Temporality
Most of the studies in [9] were case-control studies, where
either newly detected or recurrent cases of active TB were
compared to control populations. Exposure (either heavy
use or AUD) was measured retrospectively in these stud-
ies, sometimes for the past year only, or for longer time
periods. However, since AUD takes usually years to
develop, the temporal sequence of AUD before TB seems
to be confirmed in case-control studies with newly
detected TB as the outcome variable. It is hardly conceiva-
ble that the AUD could have developed after the onset of
active TB and before the subsequent interview (usually
within weeks), for example as a reaction of the patient to
being diagnosed with TB. Moreover, there are a few cohort
studies where the temporality has been clearly established
(see [22,23]).
Thus, the available evidence clearly supports a temporal
sequence with heavy alcohol use/AUD preceding TB.
Consistency
Overall, the association between heavy alcohol use/AUD
and TB is quite consistent (see additional files 1 and 2;
and the results of the three meta-analyses). The associa-
tion has been replicated in studies in different countries,
using different settings and different methodologies. For-
mal tests of consistency have been conducted in the meta-
analysis of Lönnroth and colleagues [9] for the subset of
studies which could give indicators of effect strength in
the form of RRs. Marked heterogeneity was found when
all measures of exposure were included, that is if dichoto-
mous measures of any alcohol consumption at a time
before incidence of TB (present/absent) were included [9].
This original heterogeneity decreased considerably after
subdividing studies into low- and high-exposure levels
(high-exposure defined as a measure of AUD and/or aver-
age consumption of ≥ 40 g/day). However, statistically
significant heterogeneity persisted in the high-exposure
category, which may be due to either the rather wide def-
inition of exposure (including definitions based on aver-
age volume as well as on psychiatric classification), to
misclassification of exposure across studies, to different
types of control groups used, or to the different endpoints
included (i.e., pulmonary TB vs. all TB; first incident TB vs.
recurrent TB). While heterogeneity was statistically signif-
icant, it should be stressed that no study for heavy alcohol
use/AUD showed a RR below 1, and all tests, including on
various subsets of studies controlled for different con-
founders, showed pooled RRs higher than 3 [9].
In summary, there is a consistent relationship between
heavy alcohol use/AUD and TB, and more formal meas-
ures of risk stemming from controlled studies were con-
sistently positive with relatively large effect sizes.
Dose-response relationship and impact of patterns of 
drinking
There are few studies that allow an explicit test of a dose-
response relationship between alcohol use and TB. The
work of Brown and Campbell [24] is the exception, and
from the data provided in that paper, the following odds
ratios can be calculated for different levels of exposure:
10-25 ml/day: 1.60 (95%CI: 0.57-4.55); 26-50 ml/day:
Flow diagram describing selection of studies for a systematic  review on prevalence of a) heavy alcohol use/AUD among TB  patients and b) TB among patients with AUD Figure 1
Flow diagram describing selection of studies for a sys-
tematic review on prevalence of a) heavy alcohol use/
AUD among TB patients and b) TB among patients 
with AUD.
432 potentially relevant studies identified 
and screened for retrieval 
215 studies excluded (no data on 
prevalence) 
217 studies retrieved for more information 
164 studies excluded (no sufficient 
data on prevalence) 
1,537 abstracts identified from main search 
Studies with usable information by outcome 
included in the analysis [n=53 (a=47, b=6)] 
321 duplicative studies 
784 studies excluded (no relevant 
information) BMC Public Health 2009, 9:450 http://www.biomedcentral.com/1471-2458/9/450
Page 5 of 12
(page number not for citation purposes)
2.38 (95% CI: 0.89-6.44); 51-75 ml/day: 9.27 (95% CI:
2.77-32.58); 76-100 ml/day: 8.50 (95% CI: 1.93-40.54);
>100 ml/day: 35.55 (95% CI: 6.41-260.70). However,
these findings are based on a small sample of men, and
the confidence intervals are wide. A large case-control
study of Russian mortality data [25] published as these
analyses found, in comparison to light drinkers, the fol-
lowing dose-response relationship beyond an apparent
threshold: <1 half-litre bottle of vodka or equivalent per
day relative risk 1.01 for men (95% CI 0.83-1.22), 0.93 for
women (95% CI 0.64-1.35); one to less than 3 bottles
1.97 for men (95% CI 1.64-2.36), 4.06 for women (95%
CI 2.97-5.56); 3 bottles and above 4.14 for men (95% CI
3.44-4.98), 5.32 for women (95% CI 3.70-7.65).
Most other studies use dichotomous exposure with some
variant of alcohol "abuse", either operationalized as aver-
age heavy drinking or by using AUD as the defining crite-
rion. Assuming an exponential dose-response
relationship like that found in the studies cited above is
true, one would of course expect that any dichotomous
variable associated with heavy drinking would be signifi-
cant. AUD are strongly associated with frequency of heavy
drinking occasions, and thus with overall volume of alco-
hol consumption [26,27]. Thus, the current evidence does
not contradict an exponential dose-response relationship
between average volume of alcohol use and TB. Clarifying
the exact relationship between alcohol exposure and TB
should be one of the priorities of future research, includ-
ing a test for gender-specific relationships. But also, inde-
pendent of a diagnosis of AUD, patterns of drinking have
been identified as a risk factor for a number of disease cat-
egories over and above volume of consumption [28], and
this line of investigation should be extended to TB as an
outcome as well.
In summary, there is some evidence for a dose-response
relationship between level of alcohol use and risk for TB.
Pathways I: Alcohol and susceptibility to tuberculosis
About one-third of the people in the world are infected
with M. tuberculosis [29]. Ninety percent of individuals in
the general population who become infected with M.
tuberculosis will never develop clinical disease [30]. That
means that the majority of people infected with M. tuber-
culosis, those who have an adequate immune system, are
able to fight off the infection and do not develop the dis-
ease. Only about 10% of those infected develop active TB,
where the immune system is not able to fight off the infec-
tion [31].
Research to date has shown that heavy alcohol use/AUD
is a risk factor for an impaired immune system, and
increases a person's susceptibility to active TB infection as
well as to the reactivation of latent disease [5,31-34]. Alco-
hol-consuming hosts are considered "immuno-compro-
mised" because the incidence and severity of infectious
diseases among them are greater than for abstainers [5,33-
36]. Individuals with alcohol dependence are particularly
susceptible to lung infections such as TB and pneumonia
[5,32-34].
Greater than 90% of inhaled M. tuberculosis bacteria are
normally destroyed by alveolar macrophages [37]. If alve-
olar macrophages are not able to kill M. tuberculosis, the
bacteria multiply within macrophages, and tubercles form
in the lungs. In vitro studies have shown that intracellular
survival and growth of M. tuberculosis within human mac-
rophages is enhanced by exposure to alcohol [38-40]. It
has also been shown that alcohol use exacerbates murine
pulmonary TB, which is associated with alterations in the
region-specific CD4+- and CD8+-lymphocyte responses
and defective lung granuloma formation [41]. In vivo and
in vitro studies have demonstrated that alcohol signifi-
cantly hinders antimycobacterial defenses by suppressing
mobilization, adherence, phagocytosis, and superoxide
production of alveolar macrophages [42-45]. Chronic eth-
anol ingestion in rats significantly decreases membrane
expression of the GM-CSF receptor in alveolar macro-
phages and, in parallel, decreases cellular expression and
nuclear binding of the transcription factor that activates
GM-CSF-dependent macrophage functions [46].
Acute and chronic alcohol exposure may decrease the acti-
vation of antigen-specific T-cells by inhibiting the macro-
phage's capacity to present mycobacterial antigen to
lymphocytes [47]. In addition, alcohol has been shown to
reduce macrophage response to immune system modifi-
ers (e.g., cytokines, including interleukin-6 (IL-6), IL-1β,
TNF-α, and IL-8) and to prevent the protective effect
exerted by the cytokines [40,48]. Moreover, acute and
chronic alcohol exposure may suppress the capacity of
monocytes to produce cytokines, which directly inhibit
bacterial growth and play a critical role in cellular com-
munication, activation, proliferation, and migration, as
well as regulating inflammation and healing mechanisms
[48,49]. Finally, alcohol may adversely affect antigen-spe-
cific T-cell activation so that the Th2 population (humoral
immunity) dominates the Th1 population (cell-mediated
immunity, responsible for overcoming TB infection). This
shift disturbs a balance between the two basic types of
immune system, compromising the immune defense and
increasing susceptibility to TB as a result of alcohol expo-
sure [42-45,50].
The contribution of alcohol to TB through its effects on
the immune system has been difficult to isolate from
other adverse factors, as it is still not known whether alco-
hol per se or the other sequelae of heavy drinking and alco-
hol dependence such as liver damage, nutritionalBMC Public Health 2009, 9:450 http://www.biomedcentral.com/1471-2458/9/450
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deficiency, or hygienic factors are primarily responsible
for the impaired immunity associated with alcohol
dependence [5,33,51,52]. However, by whatever mecha-
nism, alcohol exposure clearly has an impact on weaken-
ing the immune system and thus on the incidence of
active TB.
In sum, there is good evidence for a biological plausibility
of causal relationship between alcohol exposure and inci-
dence of TB via weakening the immune system.
Pathways II: Social marginalization and drift
AUD and TB have both been labeled "diseases of poverty",
and both can be consequences as well as causes of social
marginalization [5,53,54]. TB incidence follows a socioe-
conomic gradient, where TB is more incident and preva-
lent in poorer areas, and among poorer households [54].
The relationship between socioeconomic status and heavy
alcohol use/AUD is more complex. On the country level,
higher GDP has been strongly associated with higher lev-
els of alcohol use and lower abstainer rates [55,56].
Within countries, while lower socioeconomic strata often
have higher rates of abstention, rates of AUD are not nec-
essarily lower; but stigma and health harm attached to
alcohol use have been found higher in lower compared to
higher strata [56-59]. Furthermore, among specific groups
such as the homeless or the imprisoned population, AUD
rates are much higher than in the general population [60-
65].
Causal relations are not necessarily unidirectional: pov-
erty may lead to AUD, and AUD may thus be on the causal
pathway from poverty to increased TB risk. On the other
hand, AUD can lead to downward social mobility, and
such downward mobility can create or reinforce social
conditions that increase the risk of TB.
Social marginalization and the associated conditions such
as crowding, malnutrition, homelessness, and imprison-
ment increases the risk of TB independently of heavy AUD
[9]. This means that we should not consider all of the rela-
tionship between heavy alcohol use/AUD and TB as
causal. But in most studies heavy alcohol use/AUD
emerges as a significant independent risk factor for TB,
even if other risk factors are controlled for [9].
In sum, there is evidence of a social marginalization and
drift pathway on how alcohol could lead to TB.
Reversibility - effect of removing heavy alcohol exposure
Unfortunately, our second search on causal criteria (see
above) did not yield any controlled trials on the impact of
removing heavy alcohol exposure/treatment for AUD on
incidence or re-infection of TB. On the aggregate level, we
can learn from the natural experiment of the Gorbachev-
era campaign which reduced alcohol use in the Soviet
Union [66]. In the mid-eighties, the Gorbachev govern-
ment, through a variety of measures including a decrease
in the state controlled production of alcohol, succeeded in
markedly reducing per capita consumption of alcohol
between 1984 and 1987 from 14.2 l to 10.7 l of pure alco-
hol (-24.6%). These numbers take into account unre-
corded consumption such as illegally produced
moonshine [67]. After the campaign, alcohol use went
back to old levels (1993: 14.5 l; + 35.5% from 1987). At
the same time TB mortality showed similar trends for both
Russia and the Ukraine (see Table 1).
Of course, the above data are only ecologic, and alterna-
tive explanations cannot be excluded. It is reasonable to
believe that dramatic changes in both socioeconomic con-
ditions and gradients, as well as the functioning of public
health care systems, contributed to the upsurge in TB inci-
dence in Russia during the 1990s [68]. However, for the
reduction of overall mortality between 1984 and 1987,
there are not a lot of alternative explanations. In addition,
the reduction of mortality was not uniform across all
causes of death. In line with the explanation of a causal
impact of alcohol, causes of death 100% attributable to
alcohol (e.g. alcohol poisoning) showed higher mortality
rate decreases, and causes where no impact was expected
(e.g., cancer, where any impact of alcohol should be long
term and no effect in the first years can be expected [69])
showed no change at all. In addition, other countries in
Eastern Europe without a parallel reform did not show
decreases between 1984 and 1987 (e.g., Romania showed
an increase of 38.8% in men and of 13.0% in women;
own calculations - see Table 1). On the other hand, for the
increases in TB mortality after 1987 several explanations
are possible. The Soviet Union broke apart, the economic
situation in countries like Russia, Ukraine or Romania
worsened, and unemployment and other indicators of
social crisis increased. Thus, TB as a disease category
linked to poverty would be expected to increase. It is no
surprise in this situation that TB rates in a country like
Romania also increased (99.0% in men, 128.1% in
women).
Alcohol in the clinical course of tuberculosis
In addition to alcohol's role in the onset of TB, there is
also strong evidence of a negative influence of heavy
drinking/AUD on the clinical course of TB [70-74]. People
drinking heavily or with AUD show higher relapse rates
[75], a higher probability of an unfavourable clinical
course, and a higher probability of experiencing the most
destructive forms of TB [76-78]. Recent studies have also
shown that heavy drinking is positively associated with
early relapse (OR 17.7) [79]. There are several reasons thatBMC Public Health 2009, 9:450 http://www.biomedcentral.com/1471-2458/9/450
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the clinical course of TB is worse in those with AUD than
in others - both clinical and social.
Immunosuppression and altered pharmacokinetics of drugs used in 
treatment of TB
One of the major factors in increased risk for the onset of
TB and its malignant clinical course is the alteration of
immunoregulation resulting in immune deficiency,
which leads to increased vulnerability to bacterial agents
[80]. These changes affect the immune system as a whole
(see above), but, as the elimination of ethanol also occurs
by exhalation, it can have local pulmonary effects [81].
Another clinical reason for a worsened course of TB in
heavy drinkers is the changes of drug pharmacokinetics.
In particular, studies of the pharmacokinetics of isoni-
azide in the treatment of TB co-morbid with alcohol
dependence have shown significant decreases in absorp-
tion of the drug and its accelerated metabolism after oral
administration to heavy drinkers [82]. This was a cause of
a lowered maximum concentration and shorter half-life of
the drug.
The treatment of TB is also more difficult to manage in
HIV-infected patients, particularly with regard to pharma-
cological interactions. Some antibiotics used in treatment
of tuberculosis (e.g. rifampin) and protease inhibitors
share the CYP450 metabolic pathways that lead to signif-
icant changes of pharmacokinetics of these drugs when
they are prescribed simultaneously. TB-therapies lower
the concentrations of protease inhibitors: amprenavir,
lopinavir/ritonavir and atazanavir [83]. Moreover, com-
mon anti-TB medications rifampicin and rifabutin lower
the blood levels of nevirapine, efavirenz and delavirdine
to sub-therapeutic levels. Low trough plasma levels of
these anti-retroviral drugs may lead to HIV-resistance
[84]. Alcohol metabolism involves oxidative and non-oxi-
dative pathways. In the first step of oxidation, ethanol is
converted to acetaldehyde. Alcohol dehydrogenase is the
major enzyme. The microsomal ethanol-oxidizing system
(MEOS) involves several cytochrome P450 isoenzymes, of
which cytochrome P450 2E1 (CYP2E1) is the major con-
stituent [85]. The risk of liver disease is related to the
amount of alcohol consumed, but genetic factors, female
sex, obesity, chronic viral hepatitis, hepatotoxins, and
nutritional impairment all accelerate the disease process.
Alcohol even in small doses taken together with therapies
produces interactions leading to adverse events [85]. Also,
it has been shown that both TB-therapies and antiretrovi-
ral medications may have hepatotoxic effects additive to
each other [83]. That may be explained by the fact that
several xenobiotics that are metabolized by CYP2E1 have
a synergistic effect with ethanol in the generation of liver
damage.
Social exclusion and re-infection
It has been shown that having active TB leads to social
exclusion and deterioration in the social environment -
adverse effects on financial status and employment, and
consequently a worsening of living conditions. This may
lead to further exposure to M. tuberculosis in overcrowded
places, including prisons [71,86-88]. Thus, another rea-
son for a worsened course of TB is re-infection, which is
common for socially derogated and/or marginalized peo-
ple, in particular with alcohol dependence [89,90]. Social
exclusion and alcohol dependence together also lead to
delays in seeking and starting the treatment of TB, worsen-
ing its course in that way [91].
Interruption and other impediments of treatment
One of the major consequences of the deterioration of liv-
ing and financial conditions which often accompanies
alcohol dependence is an interruption of treatment
[92,93]. Its rate is significantly higher in patients living
with alcohol dependence and/or in fragile living condi-
tions [73,94-96]. A recent study shows that among
patients with TB who interrupted the course of treatment,
47.7% were heavy drinkers. The odds ratio for an inter-
ruption of treatment was 3.8 for heavy drinkers compared
to other patients [71]. Retrospective analysis of case histo-
ries has shown a similar higher risk in alcohol users of
default specifically for multidrug resistant TB treatment
with a hazard ratio of 4.26 (95% CI: 2.09-8.68) [97].
These data have been corroborated by other research
projects carried out on TB patients (e.g., [98]). The most
recent systematic review showed a pooled odds ratio of
3.03 (95% CI: 1.84 - 4.99) for alcohol dependence as a
default predictor [99].
Drug-resistant forms
A complex of factors -- immunosuppression, changes in
drug pharmacokinetics, social deprivation and interrup-
tions of treatment - leads to a lack of effectiveness of the
Table 1: Comparison of standardized mortality rates in Russia 
and the Ukraine (adults 20-64 years of age)
Comparison 1987/84
Men Women
Russia Ukraine* Russia Ukraine*
- 24.9% - 17.9% - 19.9% - 21.6%
Comparison 1993/87
Men Women
Russia Ukraine Russia Ukraine
+ 70.7% + 37.4% + 41.7% + 26.3%
* Ukraine data were only available for 1985 instead of 1984
Basis: own calculations based on WHO mortality data bank 
(European standard population)BMC Public Health 2009, 9:450 http://www.biomedcentral.com/1471-2458/9/450
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treatment in general [100]. This can have adverse effects
on drug effectiveness for the population as a whole.
Recent studies have shown that bacteria have rapidly
developed resistance to anti-TB drugs, as a result of pro-
longed exposure of patients to inappropriate treatment
[101].
Estimates of alcohol-attributable burden of disease of TB
Based on the assumptions of Lönnroth and colleagues [9],
the proportion of TB attributable to alcohol as a risk factor
in different countries is substantial, even under conserva-
tive assumptions (right two columns of Table 2 and
[102]).
Not surprisingly, given the level of consumption [103],
the highest alcohol-attributable fractions were estimated
for Russia, and also Nigeria, Thailand and South Africa,
especially for men. Overall, about 10% of the TB globally
was estimated to be attributable to alcohol.
Discussion
Experts from eight countries in North and South America,
Australasia, Asia, and Africa, together with representatives
of the World Health Organization (WHO; Department of
Mental Health and Substance Abuse and Stop TB Depart-
ment) and UNAIDS (Regional Support Team for Eastern
& Southern Africa), met in Cape Town, South Africa in
July 2008 to examine evidence relating to the linkages
between alcohol use and TB and to consider potential
causal impacts of alcohol use on the incidence and course
of the disease. Participants reviewed the data from pub-
lished and unpublished studies referred to above and spe-
cially prepared meta-analyses and reviewed information
on biological pathways. There was general consensus of
sufficient evidence to conclude that there is a causal link-
age between heavy drinking patterns and/or AUD and the
incidence of active TB for both men and women, and that
these exposure categories are also causally linked to wors-
ening of the disease course [104]. Despite this overall con-
clusion, there are still limitations in the underlying data as
spelled out in the respective individual sections on causal
criteria.
Establishing causality is only the first step in quantita-
tively estimating the amount of alcohol-attributable mor-
tality and burden of disease. The current solution of
halving of effects to adjust for confounding is not satisfac-
tory, but more studies systematically including confound-
ers are needed first. Finally, the most important advance
would be interventions to reduce the incidence of alco-
hol-attributable TB, as well as to improve the course.
There are effective treatment interventions for heavy alco-
hol use and AUD, and brief interventions have been
shown to be effective for reducing heavy drinking [105],
and there are as well effective treatments for severe alcohol
dependence [106]. Appropriate measures could be rou-
tinely offered to those screened positively for heavy alco-
hol use and AUD. In addition, alcohol exposure at the
population level can be reduced by policy measures such
as increasing taxation on alcoholic beverages and decreas-
ing the availability of alcohol through implementing a
coherent liquor outlet policy [107,108]. Such measures
have also been shown to reduce AUD. Given the size of
the problem, effective policy measures and treatment
interventions for heavy alcohol use or AUD should be
implemented at this time for reducing the double burden
associated with AUD and TB. Moreover, randomized clin-
ical trials should be started to improve and tailor preven-
tive and treatment interventions for heavy alcohol use and
AUD during the treatment of TB.
Conclusion
The epidemiological and other evidence presented indi-
cates that heavy alcohol use/AUD constitute a risk factor
for incidence and re-infection of TB. In addition, the
course of the disease is worsened by alcohol use and in
people with AUD. Interventions to reduce the impact of
alcohol on TB should be considered.
Table 2: Alcohol-attributable fractions for TB deaths 2002
Alcohol exposure ≥ 40 g/day* Alcohol-attributable fraction (AAF) AAF 
(conservative estimate assuming 50% 
additional confounding)
Men Women Men Women Men Women
Russia 56.5% 10.2% 54.3% 17.0% 37.0% 9.2%
Nigeria 39.3% 12.8% 45.3% 19.5% 29.1% 10.8%
Thailand 35.1% 2.2% 41.2% 4.5% 25.9% 2.2%
South Africa 24.3% 6.1% 36.8% 13.0% 22.6% 6.9%
Brazil 20.1% 2.2% 28.4% 4.2% 16.6% 2.1%
China 16.2% 0.3% 23.7% 0.6% 13.2% 0.3%
India 11.4% 0.1% 19.8% 0.4% 10.9% 0.2%
Pakistan 0.3% 0.01% 0.6% 0.0% 0.3% 0.0%
* based on [17] (for methodology see [155,156]
Basis: own calculations based on RR information from [9]BMC Public Health 2009, 9:450 http://www.biomedcentral.com/1471-2458/9/450
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